Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Open AccessResearch

Upregulation of CENP-H in tongue cancer correlates with poor prognosis and progression

Wen-Ting Liao1,2,3 email, Chun-Ping Yu2 email, Dong-Hui Wu1 email, Ling Zhang2 email, Li-Hua Xu2 email, Gui-Xiang Weng2 email, Mu-Sheng Zeng2 email, Li-Bing Song2 email and Jin-Song Li1 email

Department of Oral & Maxillofacial Surgery, The Second Affiliated Hospital of Sun Yat-sen University, Guangzhou, PR China

State Key Laboratory of Oncology in Southern China, Department of Experimental Research, Sun Yat-sen University Cancer Center, Guangzhou, PR China

Key Laboratory of Molecular Tumor Pathology of Guangdong Province, Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, PR China

author email corresponding author email

Journal of Experimental & Clinical Cancer Research 2009, 28:74doi:10.1186/1756-9966-28-74

Published: 5 June 2009

Additional files

Additional file 1:

Validation for the specificity of CENP-H antibody. Tongue cancer sections were incubated with CENP-H antibody alone or previously co-incubated and thereby blocked with recombinant CENP-H polypeptide.

Format: DOC Size: 4.6MB Download file

This file can be viewed with: Microsoft Word Viewer


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.